100 related articles for article (PubMed ID: 16629121)
1. F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.
Jordheim LP; Cros E; Galmarini CM; Dumontet C; Bretonnet AS; Krimm I; Lancelin JM; Gagnieu MC
Nucleosides Nucleotides Nucleic Acids; 2006 Mar; 25(3):289-97. PubMed ID: 16629121
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.
Malspeis L; Grever MR; Staubus AE; Young D
Semin Oncol; 1990 Oct; 17(5 Suppl 8):18-32. PubMed ID: 1699279
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
Gandhi V; Huang P; Chapman AJ; Chen F; Plunkett W
Clin Cancer Res; 1997 Aug; 3(8):1347-55. PubMed ID: 9815818
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes.
Fraternale A; Rossi L; Magnani M
Biochim Biophys Acta; 1996 Oct; 1291(2):149-54. PubMed ID: 8898876
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
6. The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.
Cividini F; Pesi R; Chaloin L; Allegrini S; Camici M; Cros-Perrial E; Dumontet C; Jordheim LP; Tozzi MG
Biochem Pharmacol; 2015 Mar; 94(2):63-8. PubMed ID: 25656700
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.
Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L
Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II.
Walldén K; Nordlund P
J Mol Biol; 2011 May; 408(4):684-96. PubMed ID: 21396942
[TBL] [Abstract][Full Text] [Related]
9. The 5'-nucleotidases as regulators of nucleotide and drug metabolism.
Hunsucker SA; Mitchell BS; Spychala J
Pharmacol Ther; 2005 Jul; 107(1):1-30. PubMed ID: 15963349
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I).
Tkacz-Stachowska K; Lechward K; Skladanowski AC
Acta Biochim Pol; 2005; 52(4):789-96. PubMed ID: 15940349
[TBL] [Abstract][Full Text] [Related]
11. Regulation and activity of cytosolic 5'-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism.
Bretonnet AS; Jordheim LP; Dumontet C; Lancelin JM
FEBS Lett; 2005 Jun; 579(16):3363-8. PubMed ID: 15946667
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic perspectives for cN-II in cancer.
Jordheim LP; Chaloin L
Curr Med Chem; 2013; 20(34):4292-303. PubMed ID: 23992314
[TBL] [Abstract][Full Text] [Related]
13. The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.
Sampath D; Plunkett W
Cancer Res; 2000 Nov; 60(22):6408-15. PubMed ID: 11103806
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and action of fludarabine phosphate.
Plunkett W; Huang P; Gandhi V
Semin Oncol; 1990 Oct; 17(5 Suppl 8):3-17. PubMed ID: 1699280
[TBL] [Abstract][Full Text] [Related]
15. A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids.
Kemena A; Fernandez M; Bauman J; Keating M; Plunkett W
Clin Chim Acta; 1991 Aug; 200(2-3):95-106. PubMed ID: 1723357
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.
Yin W; Karyagina EV; Lundberg AS; Greenblatt DJ; Lister-James J
Biopharm Drug Dispos; 2010 Jan; 31(1):72-81. PubMed ID: 19862681
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship of cytoplasmic 5'-nucleotidase substrate sites.
Skladanowski AC; Hoffmann C; Krass J; Jastorff B; Makarewicz W
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):1001-7. PubMed ID: 8615751
[TBL] [Abstract][Full Text] [Related]
18. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
19. Soluble "high Km" 5'-nucleotidase activity in human T- and B-lymphoblasts: isolation and some properties.
Madrid-Marina V
Int J Biochem; 1990; 22(11):1283-9. PubMed ID: 2257952
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
